Belzutifan Plus Lenvatinib Approved for Common Kidney Cancer Type
The new combination is approved for patients with advanced clear cell renal cell carcinoma that progressed on or after...
Progress Against Cancer
The new combination is approved for patients with advanced clear cell renal cell carcinoma that progressed on or after...
The new approval is for certain patients with ER-positive, HER2-negative advanced breast cancer who have received at least one...
Aminolevulinic acid hydrochloride is given as a topical gel in combination with light-based therapy. The U.S. Food and Drug...
Sevabertinib received accelerated approval as first-line treatment for some lung cancers with HER2 activating mutations. The U.S. Food and...
The approval marks the first ctDNA-guided cancer therapy. The U.S. Food and Drug Administration (FDA) has granted accelerated approval...
Ropeginterferon alfa-2b-njft treats essential thrombocythemia by targeting blood-forming cells in the bone marrow. The U.S. Food and Drug Administration...
Therapy helps control excessive red blood cell production. The U.S. Food and Drug Administration (FDA) has approved rusfertide (Mimrylo)...
Daraxonrasib is approved for previously treated or systemic-therapy-ineligible metastatic pancreatic adenocarcinoma. The U.S. Food and Drug Administration (FDA) has...
Two zanidatamab-based regimens were approved for certain HER2-positive advanced gastric, gastroesophageal junction, or esophageal cancers. The U.S. Food and...
The new agent was approved in combination with daratumumab and hyaluronidase-fihj and dexamethasone for patients with resistant or refractory...